Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: A meta-analysis of randomized studies

E. P. Navarese, S. de Servi, C. Michael Gibson, A. Buffon, F. Castriota, J. Kubica, A. S. Petronio, F. Andreotti, G. de Luca

Research output: Contribution to journalArticle

Abstract

Although early percutaneous coronary intervention has been demonstrated to reduce the risk of mortality in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS), there are emerging conflicting data as to whether the catheterization needs to be done very early or whether it could be delayed while the patient receives medical therapy. The aim of the current study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing early vs. delayed invasive strategies for NSTE-ACS patients. Medline/CENTRAL and the Web were searched for RCTs comparing early vs. delayed invasive strategies for NSTE-ACS patients. The primary endpoint was all cause mortality, whereas myocardial infarction (MI), coronary revascularizations and 30-day major bleeding complications were secondary end points. Fixed or random effects models were used based on statistical heterogeneity. As a sensitivity analysis, Bayesian random effects meta-analysis was performed in addition to the classical random effects metaanalysis. A total of 5 RCTs were finally included, enrolling 4155 patients. As compared with a delayed strategy, an early invasive approach did not significantly reduce the rates of death [odds ratio (OR) 95% confidence interval (95% CI) = 0.81 (95% CI 0.60-1.09), P = 0.17], MI [OR = 1.18 (95% CI 0.68-2.05), P=0.55] or revascularizations [OR=0.97 (0.77-1.24), P = 0.82]. There was a not significant trend toward fewer major bleeding complications for the early invasive approach [OR (95% CI) = 0.76 (0.55-1.04), P = 0.08]. The present meta-analysis shows that for NSTE-ACS patients a routine early invasive strategy does not significantly improve survival nor reduce MI and revascularization rates as compared with a delayed approach.

Original languageEnglish
Pages (from-to)193-200
Number of pages8
JournalQJM
Volume104
Issue number3
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Acute Coronary Syndrome
Meta-Analysis
Odds Ratio
Confidence Intervals
Randomized Controlled Trials
Myocardial Infarction
Mortality
Hemorrhage
Myocardial Revascularization
Bayes Theorem
Percutaneous Coronary Intervention
Catheterization
Survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation : A meta-analysis of randomized studies. / Navarese, E. P.; de Servi, S.; Gibson, C. Michael; Buffon, A.; Castriota, F.; Kubica, J.; Petronio, A. S.; Andreotti, F.; de Luca, G.

In: QJM, Vol. 104, No. 3, 03.2011, p. 193-200.

Research output: Contribution to journalArticle

Navarese, EP, de Servi, S, Gibson, CM, Buffon, A, Castriota, F, Kubica, J, Petronio, AS, Andreotti, F & de Luca, G 2011, 'Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: A meta-analysis of randomized studies', QJM, vol. 104, no. 3, pp. 193-200. https://doi.org/10.1093/qjmed/hcq258
Navarese, E. P. ; de Servi, S. ; Gibson, C. Michael ; Buffon, A. ; Castriota, F. ; Kubica, J. ; Petronio, A. S. ; Andreotti, F. ; de Luca, G. / Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation : A meta-analysis of randomized studies. In: QJM. 2011 ; Vol. 104, No. 3. pp. 193-200.
@article{a59d2410a6074f96b6f243269c98b2c3,
title = "Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: A meta-analysis of randomized studies",
abstract = "Although early percutaneous coronary intervention has been demonstrated to reduce the risk of mortality in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS), there are emerging conflicting data as to whether the catheterization needs to be done very early or whether it could be delayed while the patient receives medical therapy. The aim of the current study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing early vs. delayed invasive strategies for NSTE-ACS patients. Medline/CENTRAL and the Web were searched for RCTs comparing early vs. delayed invasive strategies for NSTE-ACS patients. The primary endpoint was all cause mortality, whereas myocardial infarction (MI), coronary revascularizations and 30-day major bleeding complications were secondary end points. Fixed or random effects models were used based on statistical heterogeneity. As a sensitivity analysis, Bayesian random effects meta-analysis was performed in addition to the classical random effects metaanalysis. A total of 5 RCTs were finally included, enrolling 4155 patients. As compared with a delayed strategy, an early invasive approach did not significantly reduce the rates of death [odds ratio (OR) 95{\%} confidence interval (95{\%} CI) = 0.81 (95{\%} CI 0.60-1.09), P = 0.17], MI [OR = 1.18 (95{\%} CI 0.68-2.05), P=0.55] or revascularizations [OR=0.97 (0.77-1.24), P = 0.82]. There was a not significant trend toward fewer major bleeding complications for the early invasive approach [OR (95{\%} CI) = 0.76 (0.55-1.04), P = 0.08]. The present meta-analysis shows that for NSTE-ACS patients a routine early invasive strategy does not significantly improve survival nor reduce MI and revascularization rates as compared with a delayed approach.",
author = "Navarese, {E. P.} and {de Servi}, S. and Gibson, {C. Michael} and A. Buffon and F. Castriota and J. Kubica and Petronio, {A. S.} and F. Andreotti and {de Luca}, G.",
year = "2011",
month = "3",
doi = "10.1093/qjmed/hcq258",
language = "English",
volume = "104",
pages = "193--200",
journal = "QJM - Monthly Journal of the Association of Physicians",
issn = "1460-2725",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation

T2 - A meta-analysis of randomized studies

AU - Navarese, E. P.

AU - de Servi, S.

AU - Gibson, C. Michael

AU - Buffon, A.

AU - Castriota, F.

AU - Kubica, J.

AU - Petronio, A. S.

AU - Andreotti, F.

AU - de Luca, G.

PY - 2011/3

Y1 - 2011/3

N2 - Although early percutaneous coronary intervention has been demonstrated to reduce the risk of mortality in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS), there are emerging conflicting data as to whether the catheterization needs to be done very early or whether it could be delayed while the patient receives medical therapy. The aim of the current study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing early vs. delayed invasive strategies for NSTE-ACS patients. Medline/CENTRAL and the Web were searched for RCTs comparing early vs. delayed invasive strategies for NSTE-ACS patients. The primary endpoint was all cause mortality, whereas myocardial infarction (MI), coronary revascularizations and 30-day major bleeding complications were secondary end points. Fixed or random effects models were used based on statistical heterogeneity. As a sensitivity analysis, Bayesian random effects meta-analysis was performed in addition to the classical random effects metaanalysis. A total of 5 RCTs were finally included, enrolling 4155 patients. As compared with a delayed strategy, an early invasive approach did not significantly reduce the rates of death [odds ratio (OR) 95% confidence interval (95% CI) = 0.81 (95% CI 0.60-1.09), P = 0.17], MI [OR = 1.18 (95% CI 0.68-2.05), P=0.55] or revascularizations [OR=0.97 (0.77-1.24), P = 0.82]. There was a not significant trend toward fewer major bleeding complications for the early invasive approach [OR (95% CI) = 0.76 (0.55-1.04), P = 0.08]. The present meta-analysis shows that for NSTE-ACS patients a routine early invasive strategy does not significantly improve survival nor reduce MI and revascularization rates as compared with a delayed approach.

AB - Although early percutaneous coronary intervention has been demonstrated to reduce the risk of mortality in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS), there are emerging conflicting data as to whether the catheterization needs to be done very early or whether it could be delayed while the patient receives medical therapy. The aim of the current study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing early vs. delayed invasive strategies for NSTE-ACS patients. Medline/CENTRAL and the Web were searched for RCTs comparing early vs. delayed invasive strategies for NSTE-ACS patients. The primary endpoint was all cause mortality, whereas myocardial infarction (MI), coronary revascularizations and 30-day major bleeding complications were secondary end points. Fixed or random effects models were used based on statistical heterogeneity. As a sensitivity analysis, Bayesian random effects meta-analysis was performed in addition to the classical random effects metaanalysis. A total of 5 RCTs were finally included, enrolling 4155 patients. As compared with a delayed strategy, an early invasive approach did not significantly reduce the rates of death [odds ratio (OR) 95% confidence interval (95% CI) = 0.81 (95% CI 0.60-1.09), P = 0.17], MI [OR = 1.18 (95% CI 0.68-2.05), P=0.55] or revascularizations [OR=0.97 (0.77-1.24), P = 0.82]. There was a not significant trend toward fewer major bleeding complications for the early invasive approach [OR (95% CI) = 0.76 (0.55-1.04), P = 0.08]. The present meta-analysis shows that for NSTE-ACS patients a routine early invasive strategy does not significantly improve survival nor reduce MI and revascularization rates as compared with a delayed approach.

UR - http://www.scopus.com/inward/record.url?scp=79951483523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951483523&partnerID=8YFLogxK

U2 - 10.1093/qjmed/hcq258

DO - 10.1093/qjmed/hcq258

M3 - Article

C2 - 21262739

AN - SCOPUS:79951483523

VL - 104

SP - 193

EP - 200

JO - QJM - Monthly Journal of the Association of Physicians

JF - QJM - Monthly Journal of the Association of Physicians

SN - 1460-2725

IS - 3

ER -